1.
Chinese Journal of Cancer Biotherapy
;
(6)1996.
Artículo
en Chino
| WPRIM
| ID: wpr-581737
RESUMEN
A comparison of effectiveness of chemo-immunotherapy (CIT) using LAK/CD3AK 1-2 weeks after TACE in 74 patients with no surgical indication and TACE alone in 41 patients with moderately advanced HCC was carried out. The rates of remission between CIT group and TACE alone group were 72.4% and 40.4%(P